Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits
Tóm tắt
Từ khóa
Tài liệu tham khảo
Erlich KS. Management of herpes simplex and varicella-zoster virus infections.West J Med. 1997;166:211–215.
Miranda P, Krasny HC, Page DA, Elion CB. Species differences in the disposition of acyclovir.Am J Med. 1982;73:31–35.
de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration.J Antimicrob Chemother. 1983;12:29–37.
Vergin H, Kikuta C, Mascher H, Metz R. Pharmacokinetics and bioavailability of different formulations of acyclovir.Arzneim Forsch. 1995;45:508–515.
Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of n vitro drug product dissolution and in vivo bioavailability.Pharm Res. 1995;12:413–420.
US FDA. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid dosage forms based on a biopharmaceutics classification system. 2000; Available at: www.fda.gov/cder/guidance/2062dft.pdf. Accessed November 2, 2007.
Avdeef A. pH-metric solubility. I. Solubility-pH profiles from Bjerrum plots, Gibbs buffer and pKa in solid state.Pharm Pharmacol Commun. 1998;4:165–178.
Lund W.The Pharmaceutical Codex, Principles and Practice of Pharmaceutics. London, UK: The Pharmaceutical Press; 1994.
Krenitsky TA, Hall WW, de Miranda P, Bauchamp LM, Schaeffer HJ, Whiteman P. 6- Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.Proc Natl Acad Sci USA. 1984;81:3209–3213.
Lycke J, Malmestrom C, Stahle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.Antimicrob Agents Chemother. 2003;47:2438–2441.
Luengo J, Aranguiz T, Sepulveda J. Preliminary pharmacokinetic study to different preparations of acyclovir with β-cyclodextrin.J Pharm Sci. 2002;91:2593–2598.
Azmin MN, Florence AT, Handjani-Vila RM, Stuart FB, Vanlerberghe G, Whittaker JS. The effect of non-ionic surfactant vesicles (niosome) entrapment on the absorption and distribution of methotrexate in mice.J Pharm Pharmacol. 1985;37:237–242.
Peh KK, Yuen KH. Simple high-performance liquid chromatographic method for the determination of acyclovir in human plasma using fluorescence detection.J Chromatogr B. 1997;693:241–244.
McIntosh TJ. The effect of cholesterol content on the structure of phosphatidylcholine bilayers.Biochim Biophys Acta. 1978;51:43–58.
Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60, 80) and a sorbitan triester (span 85).Inter J Pharmaceut. 1994;105:1–6.
Schwender RA, Asanger M, Weder HG. N-alkyl-glucosides as detergents for the preparation of highly homogenous bilayer liposomes of visible size (60–240 nm) applying defined rates of detergent removal by dialysis.Biochem Biophys Res Commun. 1981;10:1055–1062.
Brigden D, Fowle A, Rosling A. Collier LH, Oxford J, eds.Developments in Antiviral Therapy. London, UK: Academic Press; 1980:53–62.